{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:50:46Z","timestamp":1726498246290},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.molimm.2008.08.264","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T11:45:21Z","timestamp":1221651921000},"page":"192-201","source":"Crossref","is-referenced-by-count":16,"title":["Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor"],"prefix":"10.1016","volume":"46","author":[{"given":"Hwa-Jung","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Suk","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Seon","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin-Hyeog","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2008.08.264_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","article-title":"Immunochemical studies on acetylcholine receptor from Torpedo californica","volume":"14","author":"Aharonov","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.molimm.2008.08.264_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.08.264_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<616::AID-IMMU616>3.0.CO;2-I","article-title":"Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor","volume":"28","author":"Barchan","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.08.264_bib5","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/j.1460-2075.1990.tb07378.x","article-title":"The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon","volume":"9","author":"Beeson","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2008.08.264_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s001250050997","article-title":"Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats","volume":"41","author":"Bellmann","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.molimm.2008.08.264_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.1996.tb21144.x","article-title":"Active suppression of diabetes after oral administration of insulin is determined by antigen dosage","volume":"778","author":"Bergerot","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2008.08.264_bib8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.274.5293.1707","article-title":"Induction of autoimmune diabetes by oral administration of autoantigen","volume":"274","author":"Blanas","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.08.264_bib9","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2008.08.264_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/(SICI)1097-4598(199610)19:10<1239::AID-MUS1>3.0.CO;2-F","article-title":"Immunotherapy in neuromuscular disorders: current and future strategies","volume":"19","author":"Drachman","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.molimm.2008.08.264_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2008.08.264_bib13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.7520604","article-title":"Treatment of murine lupus with CTLA4Ig","volume":"265","author":"Finck","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.08.264_bib14","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.91.14.6688","article-title":"Induction of anergy or active suppression following oral tolerance is determined by antigen dosage","volume":"91","author":"Friedman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.08.264_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.164.1.136","article-title":"A critical role for B7\/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade","volume":"164","author":"Girvin","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib16","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.4049\/jimmunol.151.10.5751","article-title":"Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols","volume":"151","author":"Gregerson","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2008.08.264_bib18","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.165.7.3599","article-title":"Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis","volume":"165","author":"Im","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib19","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.184.2.783","article-title":"CTLA-4: a negative regulator of autoimmune disease","volume":"184","author":"Karandikar","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.08.264_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1146\/annurev.iy.08.040190.004013","article-title":"Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes","volume":"8","author":"Lanzavecchia","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/285238a0","article-title":"Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors","volume":"285","author":"Lennon","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2008.08.264_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.08.264_bib24","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1073\/pnas.82.24.8805","article-title":"Region of peptide 125\u2013147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies","volume":"82","author":"Lennon","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.08.264_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation","volume":"14","author":"Lenschow","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.11.005","article-title":"Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis","volume":"194","author":"Li","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2249.1999.00834.x","article-title":"Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes","volume":"116","author":"Lundin","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"Maiti","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.152.3.1453","article-title":"B cells process and present lupus autoantigens that initiate autoimmune T cell responses","volume":"152","author":"Mamula","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(96)00152-X","article-title":"Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis","volume":"71","author":"Matusevicius","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/intimm\/5.9.1159","article-title":"Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity","volume":"5","author":"Metzler","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jsfa.3122","article-title":"Suppression of immune responses to beta-lactoglobulin in mice by the oral administration of peptides representing dominant T cell epitopes","volume":"88","author":"Mizumachi","year":"2008","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.molimm.2008.08.264_bib33","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/bi00523a041","article-title":"Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site","volume":"20","author":"Mochly-Rosen","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2008.08.264_bib34","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib35","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.83.19.7443","article-title":"Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen","volume":"83","author":"Nagler-Anderson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.08.264_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1113\/jphysiol.1995.sp021090","article-title":"Functional and non-functional isoforms of the human muscle acetylcholine receptor","volume":"489","author":"Newland","year":"1995","journal-title":"J. Physiol."},{"key":"10.1016\/j.molimm.2008.08.264_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1996.tb21140.x","article-title":"Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report","volume":"778","author":"Nussenblatt","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2008.08.264_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.1988.tb00778.x","article-title":"Antigen-presenting function of B lymphocytes","volume":"106","author":"Pierce","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2008.08.264_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3949\/ccjm.63.5.270","article-title":"Prevention of insulin-dependent diabetes mellitus: an overview of three trials","volume":"63","author":"Schatz","year":"1996","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.molimm.2008.08.264_bib40","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y","article-title":"Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis","volume":"28","author":"Shi","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mus.880060410","article-title":"Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle","volume":"6","author":"Souroujon","year":"1983","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.molimm.2008.08.264_bib42","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.177.11.7634","article-title":"Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25-CD4+ regulatory T cells","volume":"177","author":"Sun","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<946::AID-MUS16>3.0.CO;2-4","article-title":"Altered expression of costimulatory molecules in myasthenia gravis","volume":"23","author":"Teleshova","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.molimm.2008.08.264_bib44","first-page":"581","article-title":"Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats","volume":"64","author":"Thompson","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0167-5699(99)01445-0","article-title":"Antigen-based immunotherapy for autoimmune disease: from animal models to humans?","volume":"20","author":"Tian","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molimm.2008.08.264_bib46","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.176.4.2654","article-title":"B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice","volume":"176","author":"Tian","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib47","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.8378772","article-title":"Effects of oral administration of type II collagen on rheumatoid arthritis","volume":"261","author":"Trentham","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.08.264_bib48","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1073\/pnas.85.9.2899","article-title":"Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67\u201376 of the alpha subunit","volume":"85","author":"Tzartos","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.08.264_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.08.264_bib50","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.7680493","article-title":"Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis","volume":"259","author":"Weiner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.08.264_bib51","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.177.7.4481","article-title":"B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation","volume":"177","author":"Yan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib52","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.4049\/jimmunol.159.3.1570","article-title":"A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis","volume":"159","author":"Yoshikawa","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib53","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1749-6632.1998.tb10987.x","article-title":"IFN-gamma is required to induce experimental autoimmune myasthenia gravis","volume":"841","author":"Zhang","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2008.08.264_bib54","first-page":"571","article-title":"B\u2013T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes","volume":"77","author":"Zhang","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2008.08.264_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/eji.1830180205","article-title":"B\u2013T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat\/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor","volume":"18","author":"Zhang","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2008.08.264_bib56","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.167.8.4245","article-title":"Activation of CD25+CD4+ regulatory T cells by oral antigen administration","volume":"167","author":"Zhang","year":"2001","journal-title":"J. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158900800607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158900800607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:58:22Z","timestamp":1684540702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158900800607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S016158900800607X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2008.08.264","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}